An alternative method of SNP inclusion to develop a generalized polygenic risk score analysis across Alzheimer's disease cohorts

Polygenic risk scores (PRSs) have great clinical potential for detecting late-onset diseases such as Alzheimer's disease (AD), allowing the identification of those most at risk years before the symptoms present. Although many studies use various and complicated machine learning algorithms to determine the best discriminatory values for PRSs, few studies look at the commonality of the Single Nucleotide Polymorphisms (SNPs) utilized in these models.This investigation focussed on identifying SNPs that tag blocks of linkage disequilibrium across the genome, allowing for a generalized PRS model across cohorts and genotyping panels. PRS modeling was conducted on five AD development cohorts, with the best discriminatory models exploring for a commonality of linkage disequilibrium clumps. Clumps that contributed to the discrimination of cases from controls that occurred in multiple cohorts were used to create a generalized model of PRS, which was then tested in the five development cohorts and three further AD cohorts.The model developed provided a discriminability accuracy average of over 70% in multiple AD cohorts and included variants of several well-known AD risk genes.A key element of devising a polygenic risk score that can be used in the clinical setting is one that has consistency in the SNPs that are used to calculate the score; this study demonstrates that using a model based on commonality of association findings rather than meta-analyses may prove useful.

[1]  K. Brookes,et al.  Utilising Polygenic Risk Score Analysis for AD to Determine the “Sphere of Influence” of the APOE Isoform SNPs , 2022, Journal of Neurology & Neuromedicine.

[2]  Nick C Fox,et al.  New insights into the genetic etiology of Alzheimer’s disease and related dementias , 2022, Nature Genetics.

[3]  D. Swallow,et al.  The hazards of genotype imputation in chromosomal regions under selection: A case study using the Lactase gene region , 2021, Annals of human genetics.

[4]  N. Laird,et al.  Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes: DTNB and DLG2 , 2021, Molecular Psychiatry.

[5]  Alan J. Thomas,et al.  Genome-wide association findings from the brains for dementia research cohort , 2021, Neurobiology of Aging.

[6]  R. Plomin,et al.  Polygenic scores: prediction versus explanation , 2021, Molecular Psychiatry.

[7]  Michael Krawczak,et al.  Genotype imputation in case-only studies of gene-environment interaction: validity and power , 2021, Human Genetics.

[8]  B. de Strooper,et al.  Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores , 2021, Nature Communications.

[9]  A. Torkamani,et al.  Genotype imputation and variability in polygenic risk score estimation , 2020, Genome medicine.

[10]  Alan J. Thomas,et al.  Genetic variants in glutamate-, Aβ−, and tau-related pathways determine polygenic risk for Alzheimer's disease , 2020, Neurobiology of Aging.

[11]  Emily Baker,et al.  Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions , 2020, Frontiers in Digital Health.

[12]  V. Escott-Price,et al.  From Polygenic Scores to Precision Medicine in Alzheimer’s Disease: A Systematic Review , 2020, Journal of Alzheimer's disease : JAD.

[13]  A. Janssens,et al.  Validity of polygenic risk scores: are we measuring what we think we are? , 2019, Human molecular genetics.

[14]  Sterling C. Johnson,et al.  Non-coding variability at the APOE locus contributes to the Alzheimer’s risk , 2019, Nature Communications.

[15]  D. Stephan,et al.  An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk , 2018, Neurobiology of Aging.

[16]  J. Yokoyama,et al.  Rare TREM2 variants associated with Alzheimer’s disease display reduced cell surface expression , 2016, Acta neuropathologica communications.

[17]  X. Hua,et al.  Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data , 2016, bioRxiv.

[18]  M. Gill,et al.  Common polygenic variation enhances risk prediction for Alzheimer's disease. , 2015, Brain : a journal of neurology.

[19]  P. Visscher,et al.  Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.

[20]  Jack Euesden,et al.  PRSice: Polygenic Risk Score software , 2014, Bioinform..

[21]  J. Haines,et al.  A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death , 2014, Nature Medicine.

[22]  B. Tang,et al.  Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China , 2014, Neurobiology of Aging.

[23]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[24]  Mark T. W. Ebbert,et al.  Genetics of Alzheimer's Disease , 2013, BioMed research international.

[25]  Thomas W. Mühleisen,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.

[26]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[27]  April N. Allen,et al.  Genome-Wide Association Study for Alzheimer's Disease Risk in a Large Cohort Of Clinically Characterized And Neuropathologically Verified Subjects , 2010, Alzheimer's & Dementia.

[28]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[29]  Ituro Inoue,et al.  Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse , 2009, Journal of Human Genetics.

[30]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[31]  S. Cichon,et al.  A genome-wide association study for late-onset Alzheimer's disease using DNA pooling , 2008 .

[32]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[33]  Kenneth S Kendler,et al.  Genetic influences on measures of the environment: a systematic review , 2006, Psychological Medicine.

[34]  James W. Vaupel,et al.  The heritability of human longevity: A population-based study of 2872 Danish twin pairs born 1870–1900 , 1996, Human Genetics.